URAT1 inhibitor and use thereof
USRE50083E1 · kind E1 · reissue
0Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2022 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | Mar 29, 2042 |
Classification
- Technology area (CPC —)General
Abstract
Disclosed are a class of URAT1 inhibitor compounds and the use of such compounds. These compounds are compounds represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. Experiments show that the compounds provided by the present invention have a very good inhibitory effect on hURAT1-transported uric acid in HEK293 transfected cells, and show that such compounds have a good potential for application in the treatment of hyperuricemia or gout.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.